Please try another search
For the three months ended 31 March 2015, Lumenis Ltd revenues increased 4% to $68.5M. Net income totaled $1.6M vs. loss of $3.1M. Revenues reflect Aesthetics segment increase of 13% to $29.9M, Surgical segment increase of 3% to $25.1M, China/APAC segment increase of 23% to $23.1M, Europe segment increase of 6% to $15.1M. Net Income reflects IPO related Bank Cash Fee decrease from $4M (expense) to $0K, Research and development.
Period Ending: | Mar 31, 2015 | Dec 31, 2014 | Sep 30, 2014 | Jun 30, 2014 |
---|---|---|---|---|
Total Revenue | 68.5 | 77.23 | 74.19 | 72.49 |
Gross Profit | 36.69 | 41.52 | 39.67 | 39.07 |
Operating Income | 3.54 | 7.39 | 7.13 | 5.11 |
Net Income | 1.65 | 6.82 | 5.52 | 3.52 |
Period Ending: | Mar 31, 2015 | Dec 31, 2014 | Sep 30, 2014 | Jun 30, 2014 |
---|---|---|---|---|
Total Assets | 274.62 | 277.65 | 270.73 | 284.01 |
Total Liabilities | 172 | 177.14 | 176.31 | 197.41 |
Total Equity | 102.61 | 100.51 | 94.42 | 86.6 |
Period Ending: | Mar 31, 2015 | Dec 31, 2014 | Sep 30, 2014 | Jun 30, 2014 |
---|---|---|---|---|
Period Length: | 3 Months | 12 Months | 9 Months | 6 Months |
Cash From Operating Activities | 1.31 | 12.49 | 5.56 | 3.02 |
Cash From Investing Activities | -19.08 | -3.65 | -3.31 | -2.26 |
Cash From Financing Activities | 0.3 | 54.98 | 54.57 | 67.85 |
Net Change in Cash | -18.04 | 62.78 | 56.32 | 68.84 |
Unlock access to over 1000 metrics with InvestingPro
View advanced insights on financial statements, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review